Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Carboplatin
Sponsor: Mothaffar Rimawi